Overview

Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

Status:
Completed
Trial end date:
2016-12-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of Hydroxytriptolide(LTS) in active rheumatoid arthritis patients with an inadequate response to methotrexate.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Shanghai Pharmaceuticals Holding Co., Ltd
Treatments:
Methotrexate